Mexidant® is prescribed as a part of complex therapy by intramuscular or intravenous (jet or drip). Doses are selected individually. Begin treatment with a dose of 50-100 mg 1 -3 times a day, gradually increasing the dose to obtain a therapeutic effect. Duration of treatment and the choice of individual dose depends on the severity of the patient's condition and the effectiveness of treatment. The maximum daily dose is 800 mg.
Streaming Mexident® is administered for 5-7 minutes. For infusion introduction the drug is diluted in 200 ml of physiological 0.9% solution of sodium chloride, drip- at a rate of 60 drops per minute.
In the treatment acute disorders of cerebral circulation Mexidant® is prescribed in the first 7-8 days at a dose of 200-300 mg once a day intravenously (drip), and then intramuscularly 100 mg 3 times a day.
When traumatic lesions of the central nervous system Mexidant® is administered intravenously (drip) at a dose of 400-600 mg per day for 7-8 days, followed by continued intramuscular injection of 300 mg per day for 10-14 days.
When discirculatory encephalopathy in the phase of decompensation Mexidant® is administered intravenously in a stream or drip, in a dose of 100 mg once a day for 14 days. Then the drug is administered intramuscularly at 100 mg 2-3 times a day for the next 14 days.
For prevention dyscirculatory encephalopathy Mexident® is administered intramuscularly in a dose 100 mg 2 once a day for 10-14 days.
When intellectual-mnestic and cognitive disorders the drug is administered intramuscularly at a dose of 100-300 mg per day for 14 days.
When abstinence syndrome Mexidant® is administered in a dose of 100-200 mg intramuscularly 2-3 times in day or intravenously (toapelno) 1-2 times a day.
When neurotic disorders and vegetative-vascular dystonia the drug is administered intramuscularly at a dose of 50-400 mg per day for 14 days.